Event Driven
December 05, 2017
Event Driven, a Reorg Research product, offers real-time news and analysis on market-moving litigations, public policy changes and M&A enforcement for investors, traders and lawyers.

Event Driven Webinar Series: Antitrust Risk & Market Impact of the AET/CVS Merger, Dec. 6 at 2 p.m. ET

 

CVS' bold play for Aetna raises a number of questions. Join the Event Driven team and industry experts this Wednesday, Dec. 6, at 2:00 p.m. ET as we discuss the antitrust risk and market impact of this merger. We will explore how this vertical merger fits into the DOJ's new antitrust policies, whether it will be impacted by the ongoing battles in D.C. over the repeal and replacement of Obamacare and what changes and potential other mergers could be triggered by the deal.

Joining us on the panel discussion will be:

  • Andrew Lowenthal, Congressional Analyst, Event Driven (Moderator)

  • Nils Tracy, Senior Analyst, Event Driven (Moderator)

  • Spencer Perlman, Managing Partner & Director of Healthcare Research, Veda Partners

An open question-and-answer session will take place at the end of the discussion.

Webinar details are as follows:

  • When: Wednesday, Dec. 6, at 2:00 p.m. ET

Registration: To register for the webinar, please CLICK HERE .

More from Event Driven
The most important insight of the day
Get the Harvest Daily Digest newsletter.